Comparing Adoption of Breakthrough and “Me-too” Drugs Among Medicare Beneficiaries: a Case Study of Dipeptidyl Peptidase-4 Inhibitors

被引：0
|
作者：
Inmaculada Hernandez
Yuting Zhang
机构：
[1] University of Pittsburgh,Department of Pharmacy and Therapeutics
[2] University of Pittsburgh,Department of Health Policy and Management
来源：
Journal of Pharmaceutical Innovation | 2017年 / 12卷
关键词：
Diffusion of innovation; Prescription drugs; Medicare Part D; Medicare Advantage;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：105 / 109
页数：4
相关论文
共 50 条
  • [1] Comparing Adoption of Breakthrough and "Me-too" Drugs Among Medicare Beneficiaries: a Case Study of Dipeptidyl Peptidase-4 Inhibitors
    Hernandez, Inmaculada
    Zhang, Yuting
    JOURNAL OF PHARMACEUTICAL INNOVATION, 2017, 12 (02) : 105 - 109
  • [2] Geospatial distribution of the adoption of dipeptidyl-peptidase-4 inhibitors for type 2 diabetes among Medicare beneficiaries
    Cordes, Jack
    Glynn, Robert J.
    Walker, Alexander M.
    Schneeweiss, Sebastian S.
    SPATIAL AND SPATIO-TEMPORAL EPIDEMIOLOGY, 2025, 52
  • [3] Dipeptidyl peptidase-4 inhibitors: Multitarget drugs, not only antidiabetes drugs
    Zhao, Yunjuan
    Yang, Lin
    Zhou, Zhiguang
    JOURNAL OF DIABETES, 2014, 6 (01) : 21 - 29
  • [4] The Place of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapeutics: A "Me Too'' or "the Special One'' Antidiabetic Class?
    Godinho, Ricardo
    Mega, Cristina
    Teixeira-de-Lemos, Edite
    Carvalho, Eugenia
    Teixeira, Frederico
    Fernandes, Rosa
    Reis, Flavio
    JOURNAL OF DIABETES RESEARCH, 2015, 2015
  • [5] Angioprotektivnoe properties lowering drugs from the group of inhibitors of dipeptidyl peptidase-4
    Oskola, E. V.
    Shubina, A. T.
    Karpov, Yu. A.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (09) : 107 - 112
  • [6] Dipeptidyl peptidase-4 inhibitors/metforminBullous pemphigoid: 5 case reports
    Reactions Weekly, 2018, 1699 (1) : 101 - 101
  • [7] A Case Report of Bullous Pemphigoid Induced by Dipeptidyl Peptidase-4 Inhibitors
    Aouidad, Iman
    Fite, Charlotte
    Marinho, Eduardo
    Deschamps, Lydia
    Crickx, Beatrice
    Descamps, Vincent
    JAMA DERMATOLOGY, 2013, 149 (02) : 243 - 245
  • [8] DIPEPTIDYL PEPTIDASE-4 INHIBITORS, SULPHONYLUREAS, AND HYPOGLYCAEMIA Inclusion of the EXAMINE study in a meta-analysis of the addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia
    Boucaud-Maitre, Denis
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 353
  • [9] Dipeptidyl peptidase-4 inhibitors: Anti-diabetic drugs with potential effects on cancer
    Almagthali, Alaa G.
    Alkhaldi, Eman H.
    Alzahrani, Afnan S.
    Alghamdi, Ameera K.
    Alghamdi, Waleed Y.
    Kabel, Ahmed M.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (01) : 36 - 39
  • [10] Dipeptidyl peptidase-4 inhibitors may lower body temperature: A case-control study
    Okada, Shuichi
    Okada, Kazuya
    Okada, Junichi
    Kikkawa, Koji
    Yamada, Eijiro
    Saito, Tsugumichi
    Andou, Tetsuro
    Ohshima, Kihachi
    Niijima, Yawara
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2024, 18 (10)
12345